keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Abaloparatide TFA [TP1215]
Cat# TP1215-1mg
Size : 1mg
Brand : TargetMol
Contact local distributor :
Phone : +1 850 650 7790
Abaloparatide TFA
Catalog No. TP1215 CAS TP1215
Synonyms: BA 058 TFA, Abaloparatide TFA (247062-33-5 free base), BIM 44058 TFA
Abaloparatide TFA (BIM 44058 TFA) is a parathyroid hormone-related protein (PTHrP) analog drug used to treat osteoporosis like the related drug teriparatide.
All TargetMol products are for research or drug registration purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose in violation of laws and regulations.
Abaloparatide TFA, CAS TP1215
| Description | Abaloparatide TFA (BIM 44058 TFA) is a parathyroid hormone-related protein (PTHrP) analog drug used to treat osteoporosis like the related drug teriparatide. |
| Synonyms | BA 058 TFA, Abaloparatide TFA (247062-33-5 free base), BIM 44058 TFA |
| Molecular Weight | 4074.61 |
| Formula | C176H301N56F3O51 |
| CAS No. | TP1215 |
Storage
Solubility Information
H2O: 50 mg/mL (12.27 mM)
References and Literature
1. Taylor AD, Saag KG. Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy. Core Evid. 2019 Aug 23;14:41-50. 2. Sahbani K, Cardozo CP, Bauman WA, Tawfeek HA. Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β-arrestin recruitment than teriparatide. Physiol Rep. 2019 Oct;7(19):e14225.